Arcturus Therapeutics Holdings (ARCT) Current Assets (2018 - 2026)

Arcturus Therapeutics Holdings (ARCT) has 9 years of Current Assets data on file, last reported at $216.9 million in Q1 2026.

• Quarterly Current Assets fell 22.21% year-over-year to $216.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $216.9 million (down 22.21% YoY) and the FY2025 annual result came in at $241.4 million, down 21.09% from the prior year.
• Current Assets declined to $216.9 million in Q1 2026, from $241.4 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $424.6 million in Q1 2023 to a low of $216.9 million in Q1 2026.
• A 5-year average of $322.3 million and a median of $327.0 million in 2022 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets sank 41.4% — and 2023, when it soared 59.42%.
• Tracing ARCT's Current Assets over 5 years: stood at $403.3 million in 2022, then dropped by 4.15% to $386.6 million in 2023, then dropped by 20.85% to $306.0 million in 2024, then slipped by 21.09% to $241.4 million in 2025, then fell by 10.17% to $216.9 million in 2026.
• The last three Current Assets figures came in at $216.9 million (Q1 2026), $241.4 million (Q4 2025), and $249.2 million (Q3 2025), per Business Quant data.